473 related articles for article (PubMed ID: 23574989)
1. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions.
Harskamp RE; Lopes RD; Baisden CE; de Winter RJ; Alexander JH
Ann Surg; 2013 May; 257(5):824-33. PubMed ID: 23574989
[TBL] [Abstract][Full Text] [Related]
2. Saphenous vein graft intervention.
Lee MS; Park SJ; Kandzari DE; Kirtane AJ; Fearon WF; Brilakis ES; Vermeersch P; Kim YH; Waksman R; Mehilli J; Mauri L; Stone GW
JACC Cardiovasc Interv; 2011 Aug; 4(8):831-43. PubMed ID: 21851895
[TBL] [Abstract][Full Text] [Related]
3. Embolic protection devices in saphenous vein graft interventions.
Cragun DT; Heuser RR
J Interv Cardiol; 2006 Dec; 19(6):525-9. PubMed ID: 17107367
[TBL] [Abstract][Full Text] [Related]
4. External support in preventing vein graft failure.
Hu J; Wan S
Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):615-22. PubMed ID: 23087319
[TBL] [Abstract][Full Text] [Related]
5. Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV.
Hess CN; Lopes RD; Gibson CM; Hager R; Wojdyla DM; Englum BR; Mack MJ; Califf RM; Kouchoukos NT; Peterson ED; Alexander JH
Circulation; 2014 Oct; 130(17):1445-51. PubMed ID: 25261549
[TBL] [Abstract][Full Text] [Related]
6. The use of drug-eluting stents in venous coronary artery bypass grafts.
Hernandez-Antolín R; Alfonso F; Jimenez P
EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
[TBL] [Abstract][Full Text] [Related]
7. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
8. Vein graft failure: from pathophysiology to clinical outcomes.
de Vries MR; Simons KH; Jukema JW; Braun J; Quax PH
Nat Rev Cardiol; 2016 Aug; 13(8):451-70. PubMed ID: 27194091
[TBL] [Abstract][Full Text] [Related]
9. Current percutaneous treatment strategies for saphenous vein graft disease.
Marmagkiolis K; Grines C; Bilodeau L
Catheter Cardiovasc Interv; 2013 Sep; 82(3):406-13. PubMed ID: 22777812
[TBL] [Abstract][Full Text] [Related]
10. Saphenous vein graft intervention: a review.
Hindnavis V; Cho SH; Goldberg S
J Invasive Cardiol; 2012 Feb; 24(2):64-71. PubMed ID: 22294536
[TBL] [Abstract][Full Text] [Related]
11. Beyond embolic protection for saphenous vein graft disease.
Satler LF
Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
[No Abstract] [Full Text] [Related]
12. Embolic protection devices in saphenous percutaneous intervention.
Morís C; Lozano I; Martín M; Rondán J; Avanzas P
EuroIntervention; 2009 May; 5 Suppl D():D45-50. PubMed ID: 19736070
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
14. 'No-touch' saphenous vein harvesting improves graft performance in patients undergoing coronary artery bypass surgery: a journey from bedside to bench.
Dashwood MR; Tsui JC
Vascul Pharmacol; 2013 Mar; 58(3):240-50. PubMed ID: 22967905
[TBL] [Abstract][Full Text] [Related]
15. Safe approach for redo coronary artery bypass grafting--preventing injury to the patent graft to the left anterior descending artery.
Nishi H; Mitsuno M; Yamamura M; Tanaka H; Ryomoto M; Fukui S; Yoshioka Y; Takanashi S; Miyamoto Y
Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):253-8. PubMed ID: 21057442
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of saphenous vein graft failure: a brief overview of interventions.
Shukla N; Jeremy JY
Curr Opin Pharmacol; 2012 Apr; 12(2):114-20. PubMed ID: 22321569
[TBL] [Abstract][Full Text] [Related]
17. Saphenous vein graft disease, pathophysiology, prevention, and treatment. A review of the literature.
Guida G; Ward AO; Bruno VD; George SJ; Caputo M; Angelini GD; Zakkar M
J Card Surg; 2020 Jun; 35(6):1314-1321. PubMed ID: 32353909
[TBL] [Abstract][Full Text] [Related]
18. Saphenous Vein Graft Failure: From Pathophysiology to Prevention and Treatment Strategies.
Xenogiannis I; Zenati M; Bhatt DL; Rao SV; Rodés-Cabau J; Goldman S; Shunk KA; Mavromatis K; Banerjee S; Alaswad K; Nikolakopoulos I; Vemmou E; Karacsonyi J; Alexopoulos D; Burke MN; Bapat VN; Brilakis ES
Circulation; 2021 Aug; 144(9):728-745. PubMed ID: 34460327
[TBL] [Abstract][Full Text] [Related]
19. Poor long-term patient and graft survival after primary percutaneous coronary intervention for acute myocardial infarction due to saphenous vein graft occlusion.
Brodie BR; VerSteeg DS; Brodie MM; Hansen C; Richter SJ; Stuckey TD; Gupta N; Pulsipher M; Downey W
Catheter Cardiovasc Interv; 2005 Aug; 65(4):504-9. PubMed ID: 15988742
[TBL] [Abstract][Full Text] [Related]
20. Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery.
Scarsini R; Zivelonghi C; Pesarini G; Vassanelli C; Ribichini FL
Cardiovasc Revasc Med; 2016 Jun; 17(4):272-8. PubMed ID: 27215852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
